Federated Hermes’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-13,650
| Closed | -$1.85M | – | 2393 |
|
2021
Q1 | $1.85M | Sell |
13,650
-3,785
| -22% | -$513K | ﹤0.01% | 1135 |
|
2020
Q4 | $2.23M | Sell |
17,435
-25,835
| -60% | -$3.31M | ﹤0.01% | 1021 |
|
2020
Q3 | $4.87M | Sell |
43,270
-6,281
| -13% | -$707K | 0.01% | 733 |
|
2020
Q2 | $4.72M | Sell |
49,551
-13,864
| -22% | -$1.32M | 0.01% | 730 |
|
2020
Q1 | $5.7M | Buy |
+63,415
| New | +$5.7M | 0.02% | 595 |
|
2019
Q2 | – | Sell |
-5,646
| Closed | -$263K | – | 2257 |
|
2019
Q1 | $263K | Sell |
5,646
-88,224
| -94% | -$4.11M | ﹤0.01% | 1525 |
|
2018
Q4 | $4.09M | Sell |
93,870
-95,335
| -50% | -$4.15M | 0.01% | 795 |
|
2018
Q3 | $10.8M | Buy |
189,205
+184,178
| +3,664% | +$10.5M | 0.03% | 548 |
|
2018
Q2 | $244K | Sell |
5,027
-129,866
| -96% | -$6.3M | ﹤0.01% | 1510 |
|
2018
Q1 | $5.27M | Buy |
+134,893
| New | +$5.27M | 0.02% | 607 |
|